GE HealthCare Tops Q4 EPS Forecasts
GE HealthCare Technologies delivered solid fourth-quarter earnings, but domestic and international revenue growth remained subdued.
Medical technology and pharmaceutical diagnostics specialist GE HealthCare Technologies (NASDAQ:GEHC) reported mixed financial results for the fourth quarter of 2024 on Thursday, Feb. 13. Adjusted earnings per share (EPS) of $1.45 were a significant beat over the anticipated $1.27. Revenue of $5.32 billion roughly matched analyst expectations but showed only modest growth of 2% year over year. While profitability improved, underwhelming revenue growth suggests potential challenges in scaling further.
Overall, the quarter showcased strong earnings performance but highlighted areas needing attention, such as revenue expansion and cash flow.
Source: GE HealthCare. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year.
